> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Allergan Drug Gains Infectious Disease Designation
- URL: https://www.fdaweb.com/allergan-drug-gains-infectious-disease-designation/
- Published: 2019-11-11T12:00:00.000Z
- Updated: 2026-09-14T15:52:36.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145473

FDA has granted Allergan a Qualified Infectious Disease Product designation and fast track status for ATM-AVI (aztreonam and avibactam) for treating complicated intra-abdominal infections, complicated urinary tract infections, and hospital-acquired bacterial pneumonia/ventilator-associated bacterial pneumonia. ATM-AVI has shown activity against metallo beta-lactamase-producing Gram-negative pathogens, for which there are currently very limited treatment options, the company says. The therapy is currently in Phase 3 trials and is being jointly developed with Pfizer.